Please be advised that AstraZeneca has transferred all rights for LUMOXITI® (moxetumomab pasudotox-tdfk) to Innate Pharma S.A. as of April 1, 2020. For questions or assistance, please call InnateCares, Monday through Friday, 8 am – 8 pm Eastern Time at 1-844-694-6628.
This brief form, once completed, gives Access 360 the ability to provide select services to you. Available in English and Spanish. The Access 360 General Patient Authorization Form must be signed for you to utilize Access 360 support.
This brochure explains Medicare Parts A, B, C, and D. You will also find an overview of the current Medicare Coverage Gap.
Use this tool to learn how Access 360 can help you get the care you need